Conversely, miR-124-3p inhibits PI3K/AKT signaling by targeting the 3’UTR of Rab27a, reducing exosome secretion and thereby limiting NSCLC metastasis (55). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.